Related Experiment Videos
Detection of 23 immunogenic pneumococcal proteins using convalescent-phase serum
G Zysk1, R J Bongaerts, E ten Thoren
1Department of Medical Microbiology and Virology, University of Duesseldorf, Duesseldorf, Germany. zysk@uni-duesseldorf.de
Infection and Immunity
|May 19, 2000
Summary
Researchers screened a Streptococcus pneumoniae genomic library to identify proteins recognized by antibodies from recovered patients. This study identified 23 proteins, including known virulence factors and potential new membrane proteins, aiding in understanding pneumococcal immunity.
Area of Science:
- Microbiology
- Immunology
- Genomics
Background:
- Streptococcus pneumoniae is a major cause of bacterial pneumonia and meningitis.
- Identifying pneumococcal antigens is crucial for developing effective vaccines and diagnostics.
Purpose of the Study:
- To identify immunoreactive proteins from Streptococcus pneumoniae using a genomic expression library.
- To characterize the identified proteins, focusing on known virulence factors and novel candidates.
Main Methods:
- Screening of a Streptococcus pneumoniae genomic expression library.
- Utilizing convalescent-phase serum to detect antibody-reactive proteins.
- Characterization of identified proteins, including localization and function.
Main Results:
- Detection of six known and 17 unknown pneumococcal proteins.
- Five of the known proteins identified were surface-located virulence factors.
- Eight of the unknown proteins were identified as putative membrane proteins.
Conclusions:
- The study successfully identified several known and novel proteins from Streptococcus pneumoniae.
- The findings highlight potential new targets for vaccine development and diagnostic tools.
- Further research into the function of the novel putative membrane proteins is warranted.